DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves. See if DaVita stock can continue to rebound and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Is DaVita Stock A Buy?
Davita stock is currently trading below its 50-day moving average. While the stock is not near an ideal buying range right now, see if it goes on to form and break out from a proper base.
The kidney dialysis center operator reported -12% earnings growth in the latest quarterly report. Sales rose 5%.
Davita stock earns the No. 8 rank among its peers in the Medical-Outpatient/Home Care industry group. Addus HomeCare, Encompass Health and RadNet are among the top 5 highly rated stocks within the group.
